ZURICH, February 1, 2013 /PRNewswire/ --
Cryo-Save announced the appointment today of Ms. Evi Mattil as Chief Commercial Officer (CCO). She will be responsible for sales, marketing and communications worldwide. Ms. Mattil will be based at the company's headquarter in Zurich. With more than 225,000 stem cell samples from umbilical cord blood and umbilical cord tissue, Cryo-Save is the largest family stem cell bank in Europe.
Evi Mattil brings over 20 years of experience to Cryo-Save, having held a variety of international senior sales & marketing positions in the pharmaceutical and women's health care sector. Most recently she was Vice President Sales at Amoena Medizin-Orthopädie-Technik Gmbh (Germany). Before that she was the European Account Director at IMS Health Management Consulting (Germany) and Vice President Global Marketing at Chiron Vaccines (Germany & UK).
"Cryo-Save is delighted with this strong addition to its management. Evi's appointment underlines the company's strong focus on commercial development. She has the extensive management experience required for the Company's commercial activities as well as very strong sales and marketing skills. Her international experience is a strong asset for Cryo-Save's global activities," said Arnoud van Tulder, Cryo-Save CEO.
Evi's expertise will be invaluable in the continuous expansion of Cryo-Save's commercial activities - the storage of stem cells from umbilical cord blood and tissue: "This is an exciting opportunity for me in a dynamic, innovative and fast growing organization. Our growth in 2013 will mainly be driven by increasing the market penetration and our market share in existing markets."
Cryo-Save, the leading international family stem cell bank, stores more than 225,000 samples from umbilical cord blood and cord tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Cryo-Save has cryo-preserved samples from over 70 countries on six continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India and South Africa.
SOURCE Cryo-Save Group N.V.